CUNY Graduate Center has developed an innovative model of artificial intelligence

October 31, 2022

The world of science remains conservative and focuses on comprehensive usage of AI for the benefit of our health. A research team at the CUNY Graduate Center has developed a novel AI model to improve the accuracy and reduce the time and cost of the drug development process. The model, called CODE-AE, screens novel drug compounds to accurately predict efficacy in humans.
Tests, undergone on over 9,000 patients, show its high level of prediction of personalized drugs that could better treat conditions of individual patients.

CUNY Graduate Center has developed an innovative model of artificial intelligence

Forrester: Cybercrime to cost $12 trillion in 2025

Nvidia Teams Up With Accenture to Boost Corporate AI Use

Boston Consulting Group Unveils Report on Global Cybersecurity Talent Shortage at Global Cybersecurity Forum 2024

Prime Minister Mоrocco A. Ahannouch presented the national digital development strategy “Maroc Digital 2030”

Meta Presentation: New AI Assistant, Llama 3.2 Models, and More

Online Panel Discussion "IT Talent in LATAM: Challenges and Solutions"